Insights

Strategic partnerships Leverage Amprion's existing Mayo Clinic Labs collaboration and European licensing partner MLM Medical Labs to expand joint sales efforts, co-marketing opportunities, and access to hospital networks and biopharma trials.

Expanded testing Capitalize on the launch of SAAmplify-αSYN Plus CSF test to differentiate offerings, targeting neurology clinics, movement disorder centers, and research hospitals seeking differential diagnostics for MSA versus Parkinson’s and related disorders.

Clinical trial access Position the company to biopharma sponsors by highlighting licensing deals for alpha-synuclein testing in Europe to enable trial cohorts, potentially accelerating adoption in pivotal studies and expanding international footprint.

Capacity expansion With a multi-million growth investment to expand diagnostic capacity, pursue regional reference labs and service bureaus to scale testing volume, reduce turnaround times, and win larger hospital systems contracts.

Awareness and education Target neuroscience networks, conferences, and hospital decision makers using Amprion’s publications and posters from congresses to build demand generation, clinician education, and adoption of seed amplification testing in routine practice.

Similar companies to Amprion

Amprion Tech Stack

Amprion uses 8 technology products and services including Microsoft Clarity, iCIMS, Amazon Web Services, and more. Explore Amprion's tech stack below.

Media & News

Amprion's Email Address Formats

Amprion uses at least 6 email formats:
Amprion Email FormatsExamplePercentage
First.Last@amprionme.comJohn.Doe@amprionme.com
40%
First@amprionme.comJohn@amprionme.com
33%
FLast@amprionme.comJDoe@amprionme.com
14%
Last@amprionme.comDoe@amprionme.com
13%
FLast@ampriondx.comJDoe@ampriondx.com
75%
First@ampriondx.comJohn@ampriondx.com
25%

Frequently Asked Questions

What is Amprion's official website and social media links?

Minus sign iconPlus sign icon
Amprion's official website is ampriondx.com and has social profiles on LinkedIn and Crunchbase.

How much revenue does Amprion generate?

Minus sign iconPlus sign icon
As of October 2026, Amprion's annual revenue is estimated to be $10M - $25M.

What is Amprion's SIC code and NAICS code?

Minus sign iconPlus sign icon
Amprion's SIC code is 8731 - Commercial Physical and Biological Research and NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Amprion have currently?

Minus sign iconPlus sign icon
As of October 2026, Amprion has approximately 38 employees across 2 continents, including Europe and North America. Key team members include Leiter Customer Management: S. M., Leiter Sicherheitsmanagement: M. R. and Manager: M. R. Explore Amprion's employee directory with LeadIQ.

What industry does Amprion belong to?

Minus sign iconPlus sign icon
Amprion operates in the Biotechnology Research industry.

What technology does Amprion use?

Minus sign iconPlus sign icon
Amprion's tech stack includes Microsoft Clarity, iCIMS, Amazon Web Services, WordPress, Brevo, Office 365, Webflow and KnowBe4.

What is Amprion's email format?

Minus sign iconPlus sign icon
Amprion's email format typically follows the pattern of First.Last@amprionme.com. Find more Amprion email formats with LeadIQ.

How much funding has Amprion raised to date?

Minus sign iconPlus sign icon
As of October 2026, Amprion has raised $17M in funding. The last funding round occurred on Sep 25, 2024 for $6M.

When was Amprion founded?

Minus sign iconPlus sign icon
Amprion was founded in 2007.
Amprion logo

Amprion

Biotechnology ResearchCalifornia, United States11-50 Employees

Amprion is a biotechnology research company focused on precision medicine for neurodegenerative disorders through seed amplification testing. Its SAAmplify-ɑSYN biomarker test is a qualitative laboratory-developed assay that detects pathogenic alpha-synuclein to aid the diagnosis of synucleinopathies, including Parkinson's disease, Lewy body dementia, and Alzheimer's disease with Lewy bodies variant. The company is based in San Francisco, California, and operates with a small to mid-sized team.

Its customers are clinical laboratories and healthcare providers seeking diagnostic tools for neurodegenerative disorders. In 2025, Amprion announced a collaboration with Mayo Clinic Laboratories to broaden access to the SAAmplify-ɑSYN test.

Section iconCompany Overview

SIC Code
8731 - Commercial Physical and Biological Research
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2007
Employees
11-50

Section iconFunding & Financials

  • $17M

    Amprion has raised a total of $17M of funding over 3 rounds. Their latest funding round was raised on Sep 25, 2024 in the amount of $6M as a Series B.

  • $10M - $25M

    Amprion's revenue is estimated to be in the range of $10M - $25M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.